Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Heartseed, Inc. ( (JP:219A) ) has shared an announcement.
Heartseed Inc. has approved the grant of post-delivery restricted stock units to three board directors, excluding independent and non-executive members, under a stock-based compensation plan authorized at its recent shareholder meeting. The initial grant covers up to 6,649 newly issued common shares with an issue price set at ¥1,923, for a total assumed value of about ¥12.8 million.
The RSU plan requires eligible directors to remain in service for at least three business years before any shares or equivalent cash are delivered, thereby tying compensation to sustained performance and corporate value creation. The framework also outlines rules for early termination, forfeiture in cases such as serious misconduct or insolvency, and cash settlement in the event of corporate reorganizations, reinforcing alignment between management incentives, shareholder value, and potential corporate transactions.
More about Heartseed, Inc.
Heartseed Inc. is a Japan-based company listed on the Tokyo Stock Exchange that operates in the life sciences sector. The company focuses on developing advanced medical technologies and seeks to enhance corporate value through long-term, stock-based incentive structures that more closely align management interests with those of shareholders.
Average Trading Volume: 327,225
Technical Sentiment Signal: Sell
Current Market Cap: Yen43.96B
For an in-depth examination of 219A stock, go to TipRanks’ Overview page.